HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Pepti · Catalog · CJC-1295 without DAC (Mod GRF 1-29)
Growth-hormone axis · research-use
CJC-1295 without DAC wholesale & OEM supply.
Lyophilized Modified GRF (1-29) — the no-DAC, shorter-acting CJC-1295 variant — in 2 mg / 5 mg / 10 mg vials for research labs, qualified B2B buyers and private-label brands, with COA + HPLC + MS on every lot.
CJC-1295 without DACHPLC ≥ 99%MS confirmed2mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | CJC-1295 without DAC (Mod GRF 1-29) |
|---|---|
| CAS number | 446036-97-1 |
| Molecular formula | C152H252N44O42 |
| Molecular weight | 3367.9 g/mol |
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 2mg / 5mg / 10mg |
| Documentation | Batch-document availability confirmed by product, specification and applicable lot |
| Distribution scope | Research use, worldwide |
| Storage | Lyophilized powder: store at 2–8 °C protected from light for short-term handling; −20 °C for long-term storage. Ships ambient-stable for transit; keep reconstituted vials refrigerated and protected from light. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | 1 kit (10 vials) | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
About CJC-1295 without DAC (Mod GRF 1-29).
CJC-1295 without DAC, also known as Modified GRF (1-29) or tetrasubstituted GRF (1-29), is a synthetic growth-hormone-releasing hormone (GHRH) analog. It carries four amino-acid substitutions (positions 2, 8, 15 and 27) that increase enzymatic stability relative to native GRF (1-29); unlike the DAC variant it has no albumin-binding Drug Affinity Complex, giving it a lower molecular weight and a shorter circulating half-life. Supplied strictly as a research-use reference material.
Documentation
Batch documentation support for CJC-1295 without DAC (Mod GRF 1-29) lots.
batch-document availability confirmed by product, specification and applicable lot. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the CJC-1295 without DAC (Mod GRF 1-29) reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
CJC-1295 without DAC (Mod GRF 1-29) — frequently asked by B2B buyers.
How is CJC-1295 without DAC different from the DAC version?
The no-DAC form is Modified GRF (1-29) — the same tetrasubstituted GHRH sequence but without the albumin-binding Drug Affinity Complex, so it has a lower molecular weight (approx. 3367.9 g/mol vs approx. 3647 g/mol for the DAC form) and a shorter circulating half-life. Buyers specify which variant their protocol requires; we supply both as separate SKUs and can quote them on one invoice.
What documentation ships with each lot?
For the applicable lot, Pepti confirms the available document set during RFQ review. Depending on the product and lot, the set can include a COA plus a reverse-phase HPLC purity chromatogram and mass-spectrometry identity confirmation against the Mod GRF (1-29) reference profile, with lot-code traceability. The current-batch COA can be shared for review before payment.
What vial sizes and MOQ do you offer?
Standard formats are 2 mg, 5 mg and 10 mg lyophilized vials. MOQ is 1 kit (10 vials) for sample lots, with tiered pricing on 200+ vial production runs and scheduled OEM repeats above 1,000 vials. Custom fills, labeling and private-label packaging are available as services.
Is CJC-1295 without DAC often sourced alongside other peptides?
In research protocols it is frequently paired with a GHRP such as ipamorelin or GHRP-2 for complementary GHRH + GHRP coverage. We supply each as separate lyophilized vials and can quote them together. It is also commonly compared with the DAC variant and with sermorelin.
What purity and grade do you supply, and for what use?
A ≥99% HPLC purity target may be quoted; the acceptance criterion, actual result and available identity documentation must be confirmed for the applicable lot. Material is supplied strictly for laboratory research and manufacturing use, not for consumer, therapeutic or diagnostic use; buyer qualification and destination country are confirmed before invoicing.
Related compounds
Related research peptides.
Current Batch COA
Open the CJC-1295 no DAC Certificate of Analysis.
Batch-linked COA PDF for each CJC-1295 no DAC specification below, with the reported chromatographic purity and molecular-weight identity results. Independent local verification is welcome. Confirmed quality issues are eligible for replacement or refund under the quality policy.